Latest Market News

Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.

Finaccess Restauración, S.L. has closed its takeover offer for Restaurant Brands New Zealand Limited, securing approximately 98% ownership and initiating compulsory acquisition of remaining shares ahead of the company’s delisting from NZX and ASX.

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

InhaleRX Limited has announced a non-renounceable entitlement offer to raise approximately $247,668 by issuing nearly 10 million new shares at 2.5 cents each, accompanied by free attaching options. The offer opens on 5 December and closes on 17 December 2025.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

PainChek Ltd has secured FDA De Novo clearance for its Adult App, marking a pivotal entry into the US long-term care market and setting the stage for global expansion including its Infant App.

Hancock & Gore is rebranding as Schoolblazer Limited following its acquisition of Trutex, consolidating its global school uniform operations and targeting over $200 million in revenue by FY27.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Eclipse Metals has engaged BGR Group, a leading U.S. government relations firm, to strengthen its strategic positioning and funding prospects for its Greenland rare earth projects, advancing its role in Western critical minerals supply chains.

Alma Metals Limited has announced a Share Purchase Plan offering eligible Australian and New Zealand shareholders the chance to buy new shares at a 15% discount, aiming to bolster its capital base ahead of year-end.